AHR-10282,
bromfenac,
bromfenac sodium,
Duract,
ISV-303,
sodium bromfenac,
Xibrom,
BROMFENAC SODIUM,
91714-93-1,
BromSite,
120638-55-3,
UNII-9X8YF771OU,
Bronuck,
Xibrom,
bromfenac sodium salt,
CHEBI:140536,
9X8YF771OU,
Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, monosodium salt,
Sodium (2-amino-3-(4-bromobenzoyl)phenyl)acetate,
Bromday,
Prolensa,
MFCD03701673,
AHR 10282B,
AHR-10282B,
Q-200752,
sodium 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate,
2-AMINO-3-(4-BROMOBENZOYL)BENZENEACETIC ACID SODIUM SALT,
bromfenac sodium salt sesquihydrate,
sodium [2-amino-3-(4-bromobenzoyl)phenyl]acetate,
sodium 2-(2-amino-3-(4-bromobenzoyl)phenyl)acetate,
Bromfenac sodium anhydrous,
C15H11BrNO3.Na,
CHEMBL751,
SCHEMBL56644,
CTK8E6674,
DTXSID70273981,
HZFGMQJYAFHESD-UHFFFAOYSA-M,
HMS3652D21,
Bromfenac sodium, >=98% (HPLC),
2285AH,
AC-149,
AN-594,
BDBM50225143,
s4248,
AKOS000280377,
AC-9334,
API0000432,
SB17363,
AK601232,
BC005156,
BC238440,
SC-82804,
RT-011819,
FT-0080506,
FT-0084337,
FT-0602701,
FT-0660252,
SW219148-1,
KS-00000654,
sodium 2-amino-3-(4-bromobenzoyl) phenylacetate,
J-004372,
I14-15725,
Sodium; [2-amino-3-(4-bromo-benzoyl)-phenyl]-acetate,
2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SODIUM,
Benzeneacetic acid,2-amino-3-(4-bromobenzoyl)-,monosodium salt,
2-Amino-3-(4-bromobenzoyl)benzeneacetic Acid Sodium Salt Hydrate,
Brinzolamide,
Bromfenac,
Duract,
Bromfenac ophthalmic,
Bromfenac Sodium Sesquihydrate,
Bromfenac sodium [USAN],
Bromfenac ophthalmic solution,
UNII-8ECV571Y37,
91714-93-1 (sodium),
CID60725,
C15H12BrNO3.3/2H2O.Na,
Bromfenac monosodium salt sesquihydrate,
ACN-046782,
CS-O-06165,
C15-H12-Br-N-O3.3/2H2-O.Na,
B1684,
A13244,
Sodium (2-amino-3-(p-bromobenzoyl)phenyl)acetate sesquihydrate,
sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate,
91714-94-2,